Architect 3L41-20
Architect 3L41-20 (03L4120) is a cannabinoid/cannabinoid metabolite IVD (FDA Class II; FDA product code LDJ, Enzyme Immunoassay, Cannabinoids) made by Abbott Laboratories, cleared under FDA 510(k) K943998 on 4 Nov 1994 and listed in FDA GUDID since 6 Jun 2016 (UDI-DI 00380740005689), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00380740005689 | Date6 Jun 2016 | StatusListed |
| United States | FDA 510(k)SESE | NumberK943998 | Date4 Nov 1994 | StatusActive |
Official records
- AccessGUDID record 00380740005689
- FDA 510(k) database K943998
From the FDA record
- Device description
- Cannabinoids
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K943998 decided 4 Nov 1994 Active
- FDA GUDID UDI-DI 00380740005689 listed 6 Jun 2016 Listed
Timeline
- Cleared FDA 510(k) K943998
- Listed FDA GUDID 00380740005689
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Architect
- Generic name
- Cannabinoid/cannabinoid metabolite IVD, kit, enzyme immunoassay (EIA)
- Model / Ref / Catalog
- 3L41-20, 03L4120
- Primary DI / UDI-DI
- 00380740005689
- 510(k) Number
- FDA product code
- LDJ
- GMDN term
- Cannabinoid/cannabinoid metabolite IVD, kit, enzyme immunoassay (EIA)
- Device class
- Class II
- Regulation number
- 862.3870
- GUDID distribution status
- In Commercial Distribution